hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanomaKarianne G. Fleten(Oslo University Hospital), Birgit Engesæter(Norwegian Institute of Public Health)Cell Death DiscoveryDecember 12, 201610.1038/cddiscovery.2016.81Cited by 13SaveCiteExport RISWatch citationsRelated PapersDacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma|PLoS ONE|2012|15